Related Experiment Video

Updated: Sep 3, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K

A Negative Regulatory Role for RKIP in Breast Cancer Immune Response

Vu N Bach1, Jane Ding2, Miranda Yeung1

  • 1Department of Cell & Cancer Biology, College of Medicine and Life Sciences, University of Toledo, Health Science Campus, Toledo, OH 43614, USA.

Cancers
|July 27, 2022
PubMed

Insights

Raf kinase inhibitor protein (RKIP) suppresses tumors and metastasis by downregulating immune response pathways in breast cancer cells. This finding offers new therapeutic strategies for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Raf kinase inhibitor protein (RKIP) is a known suppressor of cancer progression and metastasis.
  • While RKIP's inhibition of the Raf-1 pathway is established, its broader targets in cancer suppression remain unclear.
  • The role of immune response in cancer is complex, with both pro- and anti-tumorigenic effects.

Purpose of the Study:

  • To investigate whether RKIP's tumor and metastasis suppressor functions involve the modulation of immune response pathways.
  • To provide evidence for RKIP's role in downregulating immune signaling in breast cancer cells.
  • To discuss the implications of RKIP's interaction with immune response for cancer therapy.

Main Methods:

  • The study focused on analyzing signaling pathways within breast cancer cells.
  • Experimental methods were employed to assess the impact of RKIP on immune response pathways.
  • Data analysis was performed to establish the causal role of RKIP.

Main Results:

  • Evidence supports a causal role for RKIP in downregulating signaling pathways associated with immune response in breast cancer.
  • RKIP's function extends beyond the Raf-1 pathway, impacting immune mechanisms.
  • These findings suggest a novel mechanism by which RKIP suppresses tumors and metastasis.

Conclusions:

  • RKIP acts as a tumor and metastasis suppressor by downregulating immune response signaling in breast cancer.
  • Targeting RKIP's modulation of immune pathways presents a potential therapeutic strategy.
  • Further research into RKIP and immune response interactions could lead to advanced cancer treatments.
Keywords:
RKIPcytokinesimmunomodulatorinterferons

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.3K
Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP-Chip13:34

Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP-Chip

Published on: September 29, 2012

27.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K